Companion diagnostics are here to stay

Monday, December 7, 2015

The Pulse on Global Trials by Matthew Howes

The story of personalized medicine has evolved from folklore to popular science, and is destined to become classic medical literature.

[Read More]

bioMérieux acquires BioFire Diagnostics

Wednesday, September 4, 2013

bioMérieux, an in vitro diagnostics company, has acquired BioFire Diagnostics, a privately-held U.S.-based company specialized in molecular biology. BioFire invented, manufactures and commercializes its multiplex PCR FilmArray system, a simple and rapid molecular biology solution dedicated to the diagnosis of infectious diseases.

[Read More]

Two GSK melanoma drugs garner top results

Monday, June 4, 2012

GlaxoSmithKline released results from two of its phase III melanoma studies: one evaluating single agent therapy with the targeted anti-cancer agents, dabrafenib and trametinib, in patients with BRAF V600 mutation positive metastatic melanoma; and one evaluating trametinib alone.

[Read More]